对公众说真话--还没严格的证据表明板蓝根有效,他面对那个环境那个位置上这么说很需要些良知。
他在NIH提到了板蓝根是真的,准备做临床实验:
http://www3.niaid.nih.gov/topics/Flu/PDF/fluantiviral09.pdfDr. Zhong summarized studies done to assess the antiviral activity of Isatis tinctoria L extract in influenza (A/PR/8/34 (H1N1)) infected MDCK cells. These studies showed that the extract from this root could inhibit cell death in vitro. Other data suggest that Isatis tinctoria L. may interact with the HA activity of H1N1 and block RNP expression. A double-blind placebo control trial is planned to evaluate the clinical efficacy of this extract.
Dr. Zhong noted that the evidence currently available to support the use of Chinese medicinal herbs for preventing and treating influenza is not sufficient and that more randomized controlled trials are needed in this area.
无良中文媒体一如既往地歪曲,报道成“板蓝根获美国研究机构认可”:
“ 中国工程院院士、中华医学会会长钟南山做了《中国抗病毒联合治疗概述》的报告。他指出,板蓝根是抗病毒中药的典型代表,在中国有两千多年的应用历史,临床效果良好,而体外抗病毒筛选也基本证实其确切疗效。据悉,板蓝根在“非典时期”展现出来的“神奇”功效,让国外专家对其抗病毒机制产生浓厚的研究兴趣。”
“中药走向世界的一个重要的障碍就是欧美药物的准入标准,而此次美国最高研究机构资助研究中药板蓝根,具有里程碑意义,标志着美国标准对中国中医药药效的认可。”